Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Jul;62(7):2811–2817. doi: 10.1128/iai.62.7.2811-2817.1994

Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease.

C Kooi 1, A Cox 1, P Darling 1, P A Sokol 1
PMCID: PMC302886  PMID: 7516312

Abstract

Pseudomonas cepacia produces at least two extracellular proteases with apparent molecular masses of 36,000 and 40,000 Da. The 36-kDa protease has high proteolytic activity and the 40-kDa protease has low proteolytic activity with hide powder azure as a substrate. Monoclonal antibodies (MAbs) were raised against the purified 36- and 40-kDa proteases. Several MAbs directed against the 36-kDa protease were found to recognize the 40-kDa protease by Western immunoblot analysis. Similarly, a MAb directed against the 40-kDa protease recognized the 36-kDa protease, suggesting that these two proteases may be immunologically related. A MAb directed against the 36-kDa protease, designated 36-6-8, and a MAb directed against the 40-kDa protease (MAb G-11) cross-reacted with other extracellular proteases, such as Pseudomonas aeruginosa elastase and alkaline protease, Pseudomonas pseudomallei protease, and the Vibrio cholerae hemagglutinin/protease. MAb 36-6-8 neutralized the P. cepacia 36-kDa protease, P. aeruginosa elastase, P. pseudomallei protease, and V. cholerae hemagglutinin/protease but did not affect P. aeruginosa alkaline protease activity. In contrast, MAb G-11 to the 40-kDa protease neutralized only the P. cepacia 36-kDa protease. This evidence suggests that the neutralizing MAb, 36-6-8, recognizes an epitope conserved among some metalloproteases. This epitope may lie at or near the active site of the P. cepacia 36-kDa protease and P. aeruginosa elastase.

Full text

PDF
2811

Images in this article

2813Image
on p.2813
2814Image
on p.2814
2814Image
on p.2814
2815Image
on p.2815

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azghani A. O., Connelly J. C., Peterson B. T., Gray L. D., Collins M. L., Johnson A. R. Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs. Infect Immun. 1990 Feb;58(2):433–438. doi: 10.1128/iai.58.2.433-438.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baskerville A., Conlan J. W., Ashworth L. A., Dowsett A. B. Pulmonary damage caused by a protease from Legionella pneumophila. Br J Exp Pathol. 1986 Aug;67(4):527–536. [PMC free article] [PubMed] [Google Scholar]
  3. Baumann U., Wu S., Flaherty K. M., McKay D. B. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J. 1993 Sep;12(9):3357–3364. doi: 10.1002/j.1460-2075.1993.tb06009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Booth B. A., Boesman-Finkelstein M., Finkelstein R. A. Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme. Infect Immun. 1983 Nov;42(2):639–644. doi: 10.1128/iai.42.2.639-644.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Booth B. A., Finkelstein R. A. Presence of hemagglutinin/protease and other potential virulence factors in O1 and non-O1 Vibrio cholerae. J Infect Dis. 1986 Jul;154(1):183–186. doi: 10.1093/infdis/154.1.183. [DOI] [PubMed] [Google Scholar]
  6. Finkelstein R. A., Boesman-Finkelstein M., Holt P. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1092–1095. doi: 10.1073/pnas.80.4.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gessner A. R., Mortensen J. E. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol. 1990 Oct;33(2):115–120. doi: 10.1099/00222615-33-2-115. [DOI] [PubMed] [Google Scholar]
  8. Heinrich P., Rosenstein R., Böhmer M., Sonner P., Götz F. The molecular organization of the lysostaphin gene and its sequences repeated in tandem. Mol Gen Genet. 1987 Oct;209(3):563–569. doi: 10.1007/BF00331163. [DOI] [PubMed] [Google Scholar]
  9. Häse C. C., Finkelstein R. A. Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J Bacteriol. 1991 Jun;173(11):3311–3317. doi: 10.1128/jb.173.11.3311-3317.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Häse C. C., Finkelstein R. A. Comparison of the Vibrio cholerae hemagglutinin/protease and the Pseudomonas aeruginosa elastase. Infect Immun. 1990 Dec;58(12):4011–4015. doi: 10.1128/iai.58.12.4011-4015.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  12. Köhler G., Howe S. C., Milstein C. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol. 1976 Apr;6(4):292–295. doi: 10.1002/eji.1830060411. [DOI] [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. LiPuma J. J., Dasen S. E., Nielson D. W., Stern R. C., Stull T. L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990 Nov 3;336(8723):1094–1096. doi: 10.1016/0140-6736(90)92571-x. [DOI] [PubMed] [Google Scholar]
  15. MORIHARA K., TSUZUKI H. PSEUDOMONAS AERUGINOSA PEPTIDE PEPTIDOHYDROLASE. 3. SOME CHARACTERS AS A CA2+-METALLOENZYME. Biochim Biophys Acta. 1964 Nov 22;92:351–360. [PubMed] [Google Scholar]
  16. McKevitt A. I., Bajaksouzian S., Klinger J. D., Woods D. E. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun. 1989 Mar;57(3):771–778. doi: 10.1128/iai.57.3.771-778.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McKevitt A. I., Woods D. E. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol. 1984 Feb;19(2):291–293. doi: 10.1128/jcm.19.2.291-293.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakazawa T., Yamada Y., Ishibashi M. Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J Clin Microbiol. 1987 Feb;25(2):195–198. doi: 10.1128/jcm.25.2.195-198.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pavlovskis O. R., Wretlind B. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infect Immun. 1979 Apr;24(1):181–187. doi: 10.1128/iai.24.1.181-187.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rinderknecht H., Geokas M. C., Silverman P., Haverback B. J. A new ultrasensitive method for the determination of proteolytic activity. Clin Chim Acta. 1968 Aug;21(2):197–203. doi: 10.1016/0009-8981(68)90127-7. [DOI] [PubMed] [Google Scholar]
  21. Sajjan U. S., Corey M., Karmali M. A., Forstner J. F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Simmonds E. J., Conway S. P., Ghoneim A. T., Ross H., Littlewood J. M. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child. 1990 Aug;65(8):874–877. doi: 10.1136/adc.65.8.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sokol P. A., Woods D. E. Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa. Infect Immun. 1986 Mar;51(3):896–900. doi: 10.1128/iai.51.3.896-900.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sokol P. A., Woods D. E. Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein. Infect Immun. 1986 Sep;53(3):621–627. doi: 10.1128/iai.53.3.621-627.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stanker L. H., Vanderlaan M., Juarez-Salinas H. One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatography. J Immunol Methods. 1985 Jan 21;76(1):157–169. doi: 10.1016/0022-1759(85)90488-0. [DOI] [PubMed] [Google Scholar]
  26. Tablan O. C., Chorba T. L., Schidlow D. V., White J. W., Hardy K. A., Gilligan P. H., Morgan W. M., Carson L. A., Martone W. J., Jason J. M. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. doi: 10.1016/s0022-3476(85)80511-4. [DOI] [PubMed] [Google Scholar]
  27. Tablan O. C., Martone W. J., Doershuk C. F., Stern R. C., Thomassen M. J., Klinger J. D., White J. W., Carson L. A., Jarvis W. R. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 1987 Apr;91(4):527–532. doi: 10.1378/chest.91.4.527. [DOI] [PubMed] [Google Scholar]
  28. Taylor R. F., Dalla Costa L., Kaufmann M. E., Pitt T. L., Hodson M. E. Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Infect. 1992 Jul;21(3):199–204. doi: 10.1016/0195-6701(92)90076-x. [DOI] [PubMed] [Google Scholar]
  29. Thomassen M. J., Demko C. A., Doershuk C. F., Stern R. C., Klinger J. D. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Oct;134(4):669–671. doi: 10.1164/arrd.1986.134.4.669. [DOI] [PubMed] [Google Scholar]
  30. Thomassen M. J., Demko C. A., Klinger J. D., Stern R. C. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. doi: 10.1164/arrd.1985.131.5.791. [DOI] [PubMed] [Google Scholar]
  31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wandersman C. Secretion, processing and activation of bacterial extracellular proteases. Mol Microbiol. 1989 Dec;3(12):1825–1831. doi: 10.1111/j.1365-2958.1989.tb00169.x. [DOI] [PubMed] [Google Scholar]
  33. Williams A., Baskerville A., Dowsett A. B., Conlan J. W. Immunocytochemical demonstration of the association between Legionella pneumophila, its tissue-destructive protease, and pulmonary lesions in experimental legionnaires' disease. J Pathol. 1987 Nov;153(3):257–264. doi: 10.1002/path.1711530310. [DOI] [PubMed] [Google Scholar]
  34. Wretlind B., Pavlovskis O. R. Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S998–1004. doi: 10.1093/clinids/5.supplement_5.s998. [DOI] [PubMed] [Google Scholar]
  35. Yokota S., Ohtsuka H., Noguchi H. Monoclonal antibodies against Pseudomonas aeruginosa elastase: a neutralizing antibody which recognizes a conformational epitope related to an active site of elastase. Eur J Biochem. 1992 Jun 1;206(2):587–593. doi: 10.1111/j.1432-1033.1992.tb16963.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES